Abstract
Abstract: Serum neuritin and neuron-specific enolase (NSE) have predictive value for the prognosis of patients with combined traumatic brain injury (TBI) and spinal cord injury (SCI). Studying their predictive effects has positive value for disease control and treatment. Sixty patients with combined TBI and SCI were recruited and rolled into three groups according to prognosis: Group I (n=42, favorable prognosis), Group II (n=11, poor prognosis), and Group III (n=7, death). Clinical indicators were compared between the groups, and the predictive value of different indicators for prognosis was analyzed. NSE and serum neuritin levels were considerably higher in Groups II and III than in Group I (P<0.05). Multivariate logistic regression analysis showed that hypotension, NSE, serum neuritin, S100β, and combined injuries to other organs were associated with poor prognosis in patients with combined TBI and SCI. The combination of NSE and neuritin had considerably higher sensitivity (Sen), specificity (Spe), and accuracy (Acc) in predicting prognosis (P<0.05). Serum neuritin and NSE have favorable predictive value for the prognosis of patients with combined TBI and SCI. They can be actively promoted in clinical practice
Keywords
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.